Innate Pharma announces that it will participate to the MidCap Event on 21-22 September, 2009.
Hervé Brailly, CEO of Innate Pharma, and Stéphane Boissel, Executive Vice President and Chief Financial Officer, will present the Company to the investors during the MIDCAP event in Paris
Upon the occasion of the announcement of interim clinical results for IPH 1101 at the ESMO congress on Monday 21, the Company will host a conference call at 2:30pm on that same day (Details to connect to this call will be communicated on monday)
Hervé Brailly, CEO of Innate Pharma, and Stéphane Boissel, Executive Vice President and Chief Financial Officer, will present the Company to the investors during the MIDCAP event in Paris
Upon the occasion of the announcement of interim clinical results for IPH 1101 at the ESMO congress on Monday 21, the Company will host a conference call at 2:30pm on that same day (Details to connect to this call will be communicated on monday)
